Skip to the page

Data / Form D filings / Harbor BioSciences, Inc.

Harbor BioSciences, Inc.: Form D filing

Harbor BioSciences, Inc., a pharmaceuticals company in San Diego, CA, filed a Form D with the SEC in 2011. The latest, on August 12, 2011, reports $2.8 million sold of a $2.8 million offering to 1 investor.

Find out what Harbor BioSciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
9191 Towne Centre Drive, Suite 409, San Diego, CA, 92122
Phone
(858) 587-9333
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
899394

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 12, 2011New notice$2,825,000$2,825,000$01Jul 28, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Salvatore J. ZizzaDirector
James M. FrinckeExecutive Officer, Director
Marc R. SarniDirector
Robert W. WeberExecutive Officer
Jerome M. HauerDirector

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Aug 8, 2011 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Harbor BioSciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.